Who
Jack Ross
CEO and Chairman
Company insider
Files Form 4 as: CEO and Chairman, Synergy CHC.
In numbers
- Trades disclosed
- 134
- Buys
- 129
- Sells
- 0
- Bought
- $7.0M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 Apr 2015
- Last trade
- 29 Jun 2026
- Last filed
- 1 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jun 2026filed 1 Jul 2026 | Synergy CHCoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —750,000 | filing |
| 29 Jun 2026filed 1 Jul 2026 | Synergy CHCoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —750,000 | filing |
| 29 Jun 2026filed 1 Jul 2026 | Synergy CHCoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —750,000 | filing |
| 29 Jun 2026filed 1 Jul 2026 | Synergy CHCoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —750,000 | filing |
| 18 Sep 2025filed 22 Sep 2025 | Synergy CHCoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 30 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $369100 at $3.69 | filing |
| 29 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $915250 at $3.66 | filing |
| 25 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $1,365350 at $3.90 | filing |
| 24 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $1,149300 at $3.83 | filing |
| 22 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $1,062300 at $3.54 | filing |
| 11 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $2,400750 at $3.20 | filing |
| 10 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $4,4661,400 at $3.19 | filing |
| 9 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $1,260400 at $3.15 | filing |
| 8 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $2,688800 at $3.36 | filing |
| 7 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $2,282700 at $3.26 | filing |
| 3 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $5,6351,750 at $3.22 | filing |
| 2 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $12K3,750 at $3.23 | filing |
| 1 Jul 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $763250 at $3.05 | filing |
| 30 Jun 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $6,9942,600 at $2.69 | filing |
| 27 Jun 2025filed 31 Jul 2025 | Synergy CHCPharmaceuticals | SEC FORM 4 Bought | $260100 at $2.60 | filing |
News
No headline names them, or the companies they trade most, lately.